Advertisement
News
Subscribe to MDT Magazine News

The New Face of Body Contouring

September 23, 2010 6:32 am | by Bio-Medicine.Org | Comments

LOUISVILLE, Colo., Sept. 23 /- As technologies for fat removal become more advanced, physicians now have a superior choice in not only reshaping the body but also recycling the fat to further enhance appearance. According to the most recent statistics from the American Society for...

TOPICS:

Beardsworth® Selects OmniComm Systems® AE Reporting System

September 23, 2010 6:31 am | by Bio-Medicine.Org | Comments

FORT LAUDERDALE, Fla., Sept. 23 /- OmniComm Systems, Inc. (OTC: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm's...

TOPICS:

ENTrigue Surgical, Inc. Announces Initial Clinical Experience with Ventera™ Sinus Dilation Systems and the Commercial Launch of Synaero™ Hemostasis Product

September 23, 2010 5:25 am | Comments

SAN ANTONIO, Sept. 23 /PRNewswire/ -- ENTrigue Surgical, Inc. ("ENTrigue"), a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today the first clinical experience with its Ventera™ sinus dilation systems.

TOPICS:
Advertisement

Covidien raises quarterly dividend to 20 cents

September 23, 2010 4:45 am | by The Associated Press | Comments

Drug and medical device maker Covidien PLC said Thursday it is raising its quarterly dividend by 11 percent to 20 cents from 18 cents.The Irish company is also boosting its annual dividend rate to 80 cents from 72 cents.Covidien said the dividend is payable Nov. 8 to shareholders of record on...

Surefil Emerges from Chapter 11

September 23, 2010 3:33 am | by Bio-Medicine.Org | Comments

GRAND RAPIDS, Mich., Sept. 23 /- Surefil, a contract manufacturer of liquid-fill products for the personal care, home care, oral care, medical industries, and energy drinks, emerged from Chapter 11 protection with Federal Court approval on September 15, 2010. The company was able to...

TOPICS:

GSMA's Global Mobile Awards To Recognise Mobile Innovation in the mHealth Sector

September 23, 2010 3:33 am | by Bio-Medicine.Org | Comments

LONDON, Sept. 23 /- The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and...

TOPICS:

Ultrasonix Announces New Digital Ultrasound Exam Recording Technology

September 23, 2010 3:32 am | by Bio-Medicine.Org | Comments

RICHMOND, British Columbia, Sept. 23 /- Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems is pleased to announce today the introduction of SonixVCR, a software-based innovation that records, stores, and exports...

TOPICS:

DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials

September 23, 2010 1:33 am | by Bio-Medicine.Org | Comments

WILMINGTON, Del., and HEERLEN, Netherlands, Sept. 23 /- DuPont (NYSE: DD ) and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will...

TOPICS:
Advertisement

US and EU Regulatory Submissions for Vandetanib in Advanced Medullary Thyroid Cancer Accepted for Review

September 23, 2010 1:32 am | by Bio-Medicine.Org | Comments

LONDON, Sept. 23 /- AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer...

TOPICS:

New TB vaccine enters clinical testing

September 22, 2010 11:34 pm | by EurekAlert | Comments

(Aeras Global TB Vaccine Foundation) Aeras announced it will initiate a Phase I clinical trial of an investigational live recombinant tuberculosis vaccine at Saint Louis University. The new vaccine, called AERAS-422, is a modernized version of the currently used TB vaccine --...

TOPICS:

70 percent of women likely to experience sexual problems after breast cancer

September 22, 2010 11:32 pm | by EurekAlert | Comments

(Wiley-Blackwell) A new study published in the Journal of Sexual Medicine looked at whether women were more likely to experience sexual problems after breast cancer. The results showed that 70 percent of women were facing sexual function problems approximately two years post diagnosis.

TOPICS:

Meggitt Sensing Systems debuts Sensorex MEMS

September 22, 2010 7:33 pm | by I-Micronews | Comments

Model SX43040 includes triaxial inertial measurement with integral digital compensation.

New launch MEMS gyro - 100th the weight, draws 1/10th the power and is 1/3rd the cost of current MEMS gyros

September 22, 2010 7:33 pm | by I-Micronews | Comments

Leading Japanese RC model helicopter equipment manufacturer Futaba® selects Silicon Sensing?s new PinPoint® gyro

Talking while walking puts Parkinson's patients at risk for falls(2)

September 22, 2010 3:39 pm | by EurekAlert | Comments

(Florida State University) We've all heard the saying about people who can't walk and chew gum at the same time, but it turns out that walking and talking is difficult enough, especially for people with Parkinson's disease who are at increased risk for falls with injury.

TOPICS:

Talking while walking puts Parkinson's patients at risk for falls

September 22, 2010 3:38 pm | Comments

Florida State University

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading